Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,319 datasets
1,803 performance testing records from 360 Class II Biological Safety Cabinets (BSCs) in Beijing from 2018 to 2023. The dataset was created by Tao Song and measures indicators like noise, illumination, airflow velocity, and HEPA filter integrity. The analysis compares domestic and imported equipment, finding an overall qualified rate of 70.4%.
847 patient records from Pennington Biomedical Research Center enable prediction of Appendicular Lean Mass, Body Fat Percentage, and Bone Mineral Density using 3D optical imaging biomarkers. The work compares supervised models like Support Vector Regression to a semi-supervised p-Laplacian model for data-constrained environments. The dataset supports research into non-invasive alternatives to costly DXA scans.
136 patients treated with antibody-drug conjugates in early-phase clinical trials between March 2015 and March 2023 were analyzed for survival outcomes. A deep learning software, Anthropometer3DNet, automatically quantified 3D body composition parameters from pre-treatment CT scans. The data shows higher subcutaneous adipose tissue was associated with longer progression-free survival (HR=0.67) and overall survival (HR=0.66).
116 patients with pulmonary embolism were enrolled in a randomized controlled trial assessing the feasibility of distributing an evidence-based health information brochure. The study, authored by Simone Fischer, collected baseline and 4-month follow-up data on recruitment rates, PE-specific health literacy, patient knowledge, and quality of life. The dataset includes results from 75 participants who completed the follow-up, representing a 65% response rate.
Lina Chang's dataset contains clinical measurements from 247 patients with type 2 diabetes treated at Tianjin Medical University General Hospital between October 2022 and March 2025. All patients underwent a 75g oral glucose tolerance test (OGTT) with blood samples collected at five time points for glucose, insulin, C-peptide, and glucagon measurement. The data was used to examine associations between insulin resistance, impaired insulin secretion, and hyperglucagonemia.
Tana Takacova published a dataset on figshare in May 2026 containing results from a pharmacogenomic study of doxorubicin. The data likely includes EC50 cytotoxicity values for 184 human lymphoblastoid cell lines of European ancestry, genotyped for 1,126 polymorphic sites across five topoisomerase genes. It identifies a specific genetic variant, rs113270903 in TOP3A, as a biomarker for drug sensitivity.
A dataset by Tana Takacova, last updated May 2026, documents a pharmacogenomic study identifying a genetic variant linked to doxorubicin sensitivity. The analysis used genotype data from the 1,000 Human Genome and HapMap Projects to test associations with cytotoxicity EC50 values in 184 human lymphoblastoid cell lines of European ancestry. The study identified rs113270903 in the TOP3A gene as a biomarker, with variant carriers showing approximately 30% lower doxorubicin EC50.
Nine emergency department physicians from a single academic medical center completed semi-structured interviews in a qualitative study. The resulting data, authored by Rogelio A. Coronado and last updated in June 2026, organizes findings into six major themes and sub-themes regarding the implementation of nonpharmacological pain treatments.
77 patients with hematological malignancies receiving active treatment were compared to matched healthy controls for humoral and cellular vaccine responses. Seroconversion occurred in only 8% and 21% of patients after the first and second vaccine dose, versus 93% and 100% of controls. The dataset, authored by Lucia Mazzotti and last updated in May 2026, includes measurements of Spike-specific IgG titers, T-cell ELISpot assays, and T-cell receptor repertoire sequencing from baseline to six months post-vaccination.
A 51.9 KB DOCX file contains the results of a cost-utility analysis comparing two lipid-lowering strategies for acute coronary syndrome patients in Thailand. The analysis, authored by Nattiwat Promchit and last updated on 2026-05-20, uses a Markov model with data from the IMPROVE-IT trial and Thailand-specific inputs. It reports incremental cost-effectiveness ratios from societal and healthcare provider perspectives against a willingness-to-pay threshold of 160,000 THB per QALY.
A cross-sectional survey of 1,483 healthcare professionals in China, conducted by Jie Huang, examining factors influencing Traditional Chinese Medicine service use. The data includes demographic profiles, TCM-related perceptions, and actual service usage over the preceding year. The dataset was last updated on May 13, 2026.
86 patients with liver cirrhosis complicated by sepsis were prospectively enrolled at Beijing You’an Hospital between June 2023 and May 2024. The dataset includes flow cytometric analysis of PD-1 expression on lymphocyte subsets, clinical scoring systems, and 28-day mortality outcomes. The study was authored by Zhao Liu and shared under a CC-BY-4.0 license.
27 studies encompassing 30,310 patients across 14 low- and middle-income countries were analyzed to evaluate sepsis screening tools. The meta-analysis, authored by Jiale Tong and last updated in May 2026, compares the diagnostic accuracy of clinical and lab-based tools like qSOFA, NEWS, and SIRS. It reports pooled sensitivity, specificity, and AUROC metrics for each tool.
A 2025 systematic review and meta-analysis of 27 studies encompassing 30,310 patients from 14 low- and middle-income countries. It evaluates the diagnostic accuracy of sepsis screening tools like qSOFA, NEWS, MEWS, SIRS, and SOFA. The dataset was created by Jiale Tong and published on figshare under a CC-BY-4.0 license.
A cross-sectional survey of 734 healthcare workers assessed occupational fatigue using a validated scale. Latent profile analysis identified four distinct fatigue subgroups, and logistic regression explored risk factors including workload, night shifts, and environmental noise. The dataset, authored by Lanhui Tan, was last updated on 2026-05-20.
3,214 participants aged 60+ with acute respiratory symptoms were analyzed using a test-negative case-control design across three influenza seasons (2022–2025). The dataset, authored by Yang Liu and shared on figshare, provides adjusted vaccine effectiveness estimates and subgroup analyses. It was last updated on 2026-05-27.
From March 2015 to March 2023, a retrospective analysis of 136 cancer patients treated with antibody-drug conjugates (ADCs) in early-phase clinical trials. The dataset includes AI-quantified 3D body composition metrics from pre-treatment CT scans and their association with survival outcomes and toxicity. It was created by Matthieu Delaye and shared under a CC-BY-4.0 license.
A Phase III clinical trial protocol comparing a novel radio-immuno-chemotherapy regimen to standard chemotherapy for recurrent or metastatic pancreatic ductal adenocarcinoma. The study, authored by Xin Wang, plans to enroll 198 patients and measures outcomes including overall survival and progression-free survival. The dataset was last updated on 2026-05-13.
A clinical trial protocol document outlines a randomized, multicenter Phase III study comparing a novel combination therapy to standard care for recurrent or metastatic pancreatic ductal adenocarcinoma. The study, authored by Xin Wang, plans to enroll 198 patients and will assess overall survival as its primary endpoint. The document was last updated on May 13, 2026.
A scoping review of 64 randomized controlled trials involving 8,494 participants, evaluating the reporting quality of patient-reported outcomes in liver cancer treatments. The review, authored by Lu Ren and published on figshare in 2026, systematically searched six databases for RCTs of targeted therapy and/or immunotherapy published from inception to April 2025. It assessed reporting quality using the CONSORT-PRO extension and CONSORT 2010 guidelines.